SCHEMBL873144

SCHEMBL873144

CC(C)(C)O[C@@H]1C[C@@H](C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)[C@@H]4C[C@@H](OC(C)(C)C)CN4C(=O)Cc4ccccc4)cc3)cc2)N(OCCc2ccccc2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
POLB P06746 1/20 0.37
CYP2D6 P10635 3/20 0.36
S1PR1 P21453 3/20 0.36
CYP3A4 P08684 2/20 0.36
AGTR2 P50052 1/20 0.35
CYP2C9 P11712 2/20 0.34
MMP2 P08253 1/20 0.34
ANPEP P15144 1/20 0.34
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NAMPT P43490 1/20 0.33
KDM1A O60341 1/20 0.33
RCOR1 Q9UKL0 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845778 0.91 CTSS (0.43) HDAC8CTSSCTSKPOLBCYP2D6
SCHEMBL10119509 0.89 PAX8 (0.35) CYP2D6S1PR1CYP3A4CYP2C9MMP2
SCHEMBL873095 0.85 HDAC8 (0.38) HDAC8CTSSCTSKPOLBCYP2D6
SCHEMBL845768 0.82 POLB (0.49) HDAC8POLBMMP2ANPEPLMNA
SCHEMBL845491 0.81 POLB (0.55) POLBLMNAKDM4EKDM1ARCOR1
SCHEMBL845345 0.81 PAX8 (0.40) CYP2D6S1PR1CYP3A4CYP2C9MMP2
SCHEMBL845165 0.80 KDM4E (0.55) CTSKPOLBLMNAKDM4EKDM1A
SCHEMBL13272453 0.79 HDAC8 (0.37) HDAC8CTSSCTSKPOLBCYP2D6
SCHEMBL844993 0.78 MMP2 (0.40) CYP2D6S1PR1CYP3A4CYP2C9MMP2
SCHEMBL845118 0.78 POLB (0.51) POLBLMNAKDM4EKDM1ARCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed